Stockholm, July 6, 2020 / PRNewswire /- Medivir ab (Nasdaq Stockholm: MVIR) today announced that it has participated in a collaborative study with SciLifeLab’s drug development...
Development of this project began in early April and one of the researchers said it came in direct reaction Pandemic.. The results are encouraging enough to...
At that time, as a medical student, I didn’t fully understand the importance of his statement. But with the rapid spread of Covid-19 affecting communities across...
Recent Comments